about
Immune cell screening of a nanoparticle library improves atherosclerosis therapyA Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer NanomedicinesHyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in AtherosclerosisA modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targetingInhibiting macrophage proliferation suppresses atherosclerotic plaque inflammationImaging Macrophage and Hematopoietic Progenitor Proliferation in AtherosclerosisPET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein NanoparticlesAugmenting drug-carrier compatibility improves tumour nanotherapy efficacy.Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy.Synthesis and evaluation of a 125I-labeled iminodihydroquinoline-derived tracer for imaging of voltage-gated sodium channels.Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease.Applying nanomedicine in maladaptive inflammation and angiogenesis.A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis.Investigating the Cellular Specificity in Tumors of a Surface-Converting Nanoparticle by Multimodal ImagingLabeling galectin-3 for the assessment of myocardial infarction in rats.In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.Specific Binding of Liposomal Nanoparticles through Inverse Electron-Demand Diels-Alder Click Chemistry.Fluorinated indazoles as novel selective inhibitors of nitric oxide synthase (NOS): synthesis and biological evaluation.Imaging-guided revival of nanomedicine?High-Density Lipoprotein Nanobiologics for Precision Medicine.Integrating nanomedicine and imaging.Real-Time Monitoring of Nanoparticle Formation by FRET Imaging.Near-Infrared Quantum Dot and 89Zr Dual-Labeled Nanoparticles for in Vivo Cerenkov Imaging.Evaluation of a 125I-labelled benzazepinone derived voltage-gated sodium channel blocker for imaging with SPECT.PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis.Reversible Electroporation-Mediated Liposomal Doxorubicin Delivery to Tumors Can Be Monitored With 89Zr-Labeled Reporter Nanoparticles.Nanoemulsion based delivery of fluorescent PARP inhibitors in mouse models of small cell lung cancerNanobody-Facilitated Multiparametric PET/MRI Phenotyping of AtherosclerosisInhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant AcceptanceSynthesis and biological evaluation of indazole derivativesFast degenerate double proton transfer in the solid state between two indazolinone tautomersEfficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primatesSonophore-enhanced nanoemulsions for optoacoustic imaging of cancerDevelopment and Multiparametric Evaluation of Experimental Atherosclerosis in RabbitsInvestigating supramolecular systems using Förster resonance energy transferNanoimmunotherapy to treat ischaemic heart diseaseMultimodal Positron Emission Tomography Imaging to Quantify Uptake of 89Zr-Labeled Liposomes in the Atherosclerotic Vessel WallAn 89Zr-HDL PET Tracer Monitors Response to a CSF1R InhibitorImaging-assisted nanoimmunotherapy for atherosclerosis in multiple species
P50
Q28393434-D94E37AB-D212-4CDD-9048-716AFA50DE5DQ33615407-D945FE12-0F7A-44C0-9B0B-BD106B8633B1Q33856678-DF85C52C-7BFD-40CC-8466-4CAED25557BFQ35238675-B2D80079-E4A0-442B-AB02-4E56698B7565Q35964485-6BC6B2EB-2608-4374-88CE-9E7AA7B28504Q36202794-C87A0834-B23D-448F-9E18-2CF7394967C5Q36533549-89DC1CB3-DA49-494C-84F1-D9376E0F0F08Q36804366-203D939A-A6D6-4369-B7E1-A8CD43D0F889Q37024507-4705517C-117E-48E3-91DC-0216FC5AC647Q37150361-38B655BE-3F2B-47D3-B37C-A862ABD3FA2DQ37150361-3A85EA36-2B87-4530-9E2B-D25ACA79D391Q37591328-F64E6647-4C40-43B2-980F-3F51E0A76AF9Q38557650-1A01A39D-51FC-4DE4-B7C7-3C7D9C1C3C71Q38682301-C2F17ED5-A282-47A0-AA85-B3C398CAF130Q38895968-7242D253-16A9-4B15-A392-D61AED16E184Q40792117-B097BF49-FC82-42C5-98A5-58C0F5464CB7Q41534056-E56A5252-D04E-4709-8FE3-4B989412428CQ42378064-90F5A2D5-2747-454D-8556-C20BFC5F9248Q43292347-9E687101-4735-4A24-AC29-A1232A6EF995Q47115988-A3046D29-1E26-4DB2-9535-C76C1B239BBFQ47216078-ADF85AD8-4E11-4671-A3A0-0C4B1A1E7893Q47313459-4C3F5052-2DF7-4FAF-AF33-EF3789C69BBBQ48049192-FECA6669-A300-4A0F-94D8-38BE7B93933CQ48115096-9D9655B9-E1B1-47CA-9F5E-0436DDD5EDFEQ48311902-3517F625-010E-4FF1-9D28-6894CCBA9F73Q49955253-816C0CB1-9CF0-4F1C-A314-C36706DE4A76Q52685717-389E1D84-31F0-4F6E-BFFE-9689E4B1C53DQ57789995-55A558F8-D932-4999-B0E3-F6D3885CB2CCQ57815530-32AA9A2F-A999-4D55-9C24-D28F15CAAAE0Q58592065-5E21D63A-0817-4A89-92D8-A5F09D77C3AAQ60229315-667156E2-9445-4B12-A2B9-CF44BAED194AQ60229316-155571EE-74AF-4706-A3E4-9B5C2BDBB859Q63560435-7B7CAD31-FE66-4FC9-B47B-32F87E7039DCQ64218610-3AFB230F-788C-4F81-A746-6C8AA36FD55CQ89484649-35F61100-662A-431A-8455-B4F382A7EB0BQ90851080-B0DCE5DD-EF82-4C06-B746-99CD36FB0D7DQ91411240-A8C8FFB6-4ACB-4F48-ABD3-9BFBA3300CF0Q92073150-B754603B-B353-40EB-B5E1-EB31D9F134A8Q92668355-7C3E039F-3F5E-49CA-A607-E2DC8A15C511Q92756293-862A8777-81E1-4081-B45A-95CC25AA5236
P50
description
researcher ORCID ID = 0000-0002-6011-0629
@en
wetenschapper
@nl
name
Carlos Pérez-Medina
@ast
Carlos Pérez-Medina
@en
Carlos Pérez-Medina
@es
Carlos Pérez-Medina
@nl
type
label
Carlos Pérez-Medina
@ast
Carlos Pérez-Medina
@en
Carlos Pérez-Medina
@es
Carlos Pérez-Medina
@nl
prefLabel
Carlos Pérez-Medina
@ast
Carlos Pérez-Medina
@en
Carlos Pérez-Medina
@es
Carlos Pérez-Medina
@nl
P1153
15053778600
P21
P31
P496
0000-0002-6011-0629